NCT07142824 Comparison Between Burn Dressing Using Tilapia-Fish Skin Versus Regular Dressing
| NCT ID | NCT07142824 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Burns |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-07-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the use of tilapia fish skin as a healing dressing in burn patients and its clinical outcome and compare it with regular dressing.
Eligibility Criteria
Inclusion Criteria: * Patients with second or third-degree burns. Exclusion Criteria: * Patients with first-degree burns. * Patients with burn injuries complicated by sepsis. * Patients who received prior wound healing agents. * Elderly patients or those with chronic diseases such as diabetes mellitus.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07142824 clinical trial?
This trial is open to participants of all sexes, studying Burns. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07142824 currently recruiting?
Yes, NCT07142824 is actively recruiting participants. Contact the research team at osamamahmood3010@yahoo.com for enrollment information.
Where is the NCT07142824 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07142824 clinical trial?
NCT07142824 is sponsored by Sohag University. The trial plans to enroll 20 participants.